- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 0
- Grants since 2016
- 3 144
Grants received
2026–2027 · fellowship · Postdoctoral Fellowship
Decoding exercise-induced metabolic signals: mechanisms and physiological roles of 2-hydroxybutyrate in regulating HDAC6
Bingsen Zhang · Dana-Farber Cancer Institute · funded by American Heart Association
2026–2028 · award
Strategy to Enhance Tumor Infiltration by Vaccine-induced T cells
Kai Wucherpfennig · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
Potentiating antibody-drug conjugate activity by controlled co-engagement with internalizing receptor
Xin Zhou · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Genomic instability after telomere crisis shapes viral integration and Merkel cell carcinoma evolution
Jiawen Yang · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2031 · award
The African American Childhood Cancer Multiprong Psychosocial Nurse Intervention to Promote Equitable Psychosocial Outcomes in Pediatric Cancer Care
Ijeoma Eche-Ugwu · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
Direct identification and prioritization of shared noncanonical tumor-specific antigens to generate effective off-the-shelf cancer vaccines
Catherine Wu · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Does a multicomponent exercise program affect balance among endometrial and ovarian cancer patients undergoing adjuvant chemotherapy?
Salvatore Ficarra · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
Paralyzing plasticity: Developing a SOX9 inhibitor for colorectal cancer treatment
Nilay Sethi · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
Catalyzing cryptic antigen-directed vaccines for pancreatic cancer
William Freed-Pastor · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Defining shared non-canonical tumor antigens for anti-melanoma vaccines
Patrick Ott · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance
2026–2027 · research · Bridge Innovative Project Award
Immunogenicity in Mitochondrial Cardiomyopathies
Pere Puigserver · Dana-Farber Cancer Institute · funded by American Heart Association
2026–2031 · award
ASTRO: Advancing Biomarker Discovery in Prostate Cancer Through Computer Vision-Driven Profiling of Tumor and Microenvironmental Heterogeneity
David Yang · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
SMARCA4/2 Inhibition as a Therapeutic Strategy for POU2F3-positive Small Cell Lung Cancer
Cigall Kadoch · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2028 · award
Endogenous Retroviruses as Emerging Targets for Cancer Vaccines
William Kaelin · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Uncovering the intrinsic mechanisms of B7-H3 upregulation in Ewing sarcoma to enable next-generation CAR T cell therapy
Alberto Bueno-Costa · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Defining the DNA Repair Independent Mitotic Role of 53BP1
Chiara Masnovo · Dana-Farber Cancer Institute · funded by American Cancer Society
2026–2029 · award
Development of a Covalent CARM1 Inhibitor for Immunotherapy of Melanoma
Kai Wucherpfennig · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance
2026–2028 · award
ctDNA Guided Care in Patients with Metastatic Breast Cancer
Nancy Lin · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2028 · award
Targeting breast cancer cells with folate and vitamin C
Lewis Cantley · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2027 · award
Discovery of New Therapeutic Vulnerabilities in TNBC
Myles Brown · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2028 · award
Genomic relationships between gynecologic and breast cancers: mechanisms and predictors for targeted therapy efficacy and resistance
Ursula Matulonis · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2027 · award
2-Oxoglutarate Dependent Dioxglutarate Dependent Dioxygenases as Therapeutic Targets in Breast Cancer
William Kaelin · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2027 · award
Impact of Exercise on the Immunological Landscape of Benign Breast Tissue in Women with Increased Breast Density
Jennifer Ligibel · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2028 · award
Extending the Use of PARP inhibitors for Triple Negative Breast Cancer Therapy
Alan D'Andrea · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026–2028 · award
Molecular and Clinical Characterization of Germline BRCA, PALB2, and TP53–Altered ER+ Breast Cancers: Implications for Biology and Therapy
Judy Garber · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026 · facilities
Structure-guided drug discovery targeting the human IRF4 Interferon Activation Domain in Multiple Myeloma
Hyuk-Soo Seo · Dana-Farber Cancer Institute · funded by U.S. Department of Energy
2026 · research
Determining whether some patients with HER2-positive metastatic breast cancer can safely stop therapy
Stefania Morganti · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026 · research
Using AI tools to accelerate the discovery of biomarkers and treatment insights in breast cancer
Eliezer Van Allen · Dana-Farber Cancer Institute · funded by Breast Cancer Research Foundation
2026 · career development · ASH-Amos Medical Faculty Development Award (AMFDP / AIMFD)
ASH-Amos Medical Faculty Development Award (AMFDP / AIMFD) 2026: Francesca Alvarez Calderon
Francesca Alvarez Calderon · Dana-Farber Cancer Institute · funded by American Society of Hematology
2026 · research · ASH Award for Research Careers in Hematology (ARCH)
Treatment Selection Using Dynamic BH3 Profiling in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Jacqueline Garcia · Dana-Farber Cancer Institute · funded by American Society of Hematology
2026 · career development · Young Investigator Award
Mechanisms and Modulators of TFE3-Fusion Oncoproteins in Pediatric Kidney Cancer: Identifying Actionable Vulnerabilities
Cary Weiss · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2026 · research · ASH Treating Fairly Award
Targeting poverty to improve ALL trial outcomes: a randomized phase III trial evaluation of the RISE intervention
Kira Bona · Dana-Farber Cancer Institute · funded by American Society of Hematology
2026 · career development · Young Investigator Award
Effect of TET2 loss-of-function mutations on CD8+ tissue resident memory differentiation
Amy Li · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2026–2027 · research · SU2C-TORREY COAST FOUNDATION RADIOPHARMACEUTICALS FOR GASTROINTESTINAL CANCERS NEW DISCOVERY CHALLENGE
Developing Next-generation Radionuclide Theranostics for Upper Gastrointestinal Tumors
Ken Herrmann · Dana-Farber Cancer Institute · funded by Stand Up To Cancer
2026 · training · HIP Fellow Award
HIP Fellow Award 2026: Tolulope Rosanwo
Tolulope Rosanwo · Dana-Farber Cancer Institute · funded by American Society of Hematology
2026 · career development · Young Investigator Award
Molecular determinants of response and resistance to sacituzumab govitecan with and without pembrolizumab in metastatic, hormone receptor-positive breast cancer
Tess O'Meara · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Challenging the non-curative treatment paradigm for HER2+ metastatic breast cancer: Primary outcome and correlative ctDNA analysis from the STOP-HER2 trial
Stefania Morganti · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2026 · fellowship · ASH Research Training Award for Fellows (RTAF): First Year Awardees
ASH Research Training Award for Fellows (RTAF) 2026: Colleen Kelly
Colleen Kelly · Dana-Farber Cancer Institute · funded by American Society of Hematology
2026 · career development · Young Investigator Award
Integrating serial NGS-MRD with GVHD prophylaxis to improve relapse prediction after allogeneic HCT
Heardley Murdock · Dana-Farber Cancer Institute · funded by Conquer Cancer Foundation
2025–2028 · award
Deciphering T cell determinants of resistance to neoadjuvant immunotherapy
Giacomo Oliveira · Dana-Farber Cancer Institute · funded by Melanoma Research Alliance